News
1h
Zacks Investment Research on MSNIGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue EstimatesIGM Biosciences, Inc. (IGMS) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.83 per share a year ago. These ...
Power Corporation of Canada (Power Corporation or the Corporation) (TSX: POW) (TSX: POW.PR.E) today reported earnings results for the three months ended March 31, 2025.
IGM Financial Inc. ( TSE:IGM ) has announced that it will pay a dividend of CA$0.5625 per share on the 31st of ...
The Episcopal Church’s migration service is refusing a directive from the U.S. federal government to help resettle white ...
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.
Sales started to slow in the spring, as market uncertainty began to weigh on investor confidence, says CEO James O’Sullivan ...
US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...
Detailed price information for Igm Financial Inc (IGIFF) from The Globe and Mail including charting and trades.
IGM Financial Inc (IGIFF) reports record earnings and significant asset growth, while navigating market volatility and strategic challenges.
IGM Financial Inc. reported adjusted net earnings of $237.8 million for the first quarter, up 5.9% from the same quarter of ...
Cambridge, Massachusetts-based Vor Bio has confirmed that it will halt clinical and manufacturing operations, including its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results